Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.

International journal of oncology

Volumn 25, Issue 6, 2004, Pages 1677-1683

  Mehta, Neil ^a   Mauer, Ann M ^a   Hellman, Samuel ^a   Haraf, Daniel J ^a   Cohen, Ezra E W ^a   Vokes, Everett E ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; OXALIPLATIN; PACLITAXEL; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; PLEURAL EFFUSION; PROGNOSIS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 16644368518     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.25.6.1677     Document Type: Article

References (0)